Hepatitis C Virus
Research on hepatitis c virus described by J. Denis and colleagues
Published in Hepatitis Weekly, September 10th, 2007
"They were treated with Pegylated interferon plus ribavirin. At the end of therapy, HCV RNA was still detectable. Several months after stopping treatment, aminotransferase level normalized and HCV RNA became undetectable. No case of sustained viral response happening several months after therapy has been yet described," wrote J. Denis and colleagues.
The researchers concluded: "During long-term...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-09-10)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
Who will recover spontaneously from hepatitis C virus infection - HIV/AIDS
High-risk behaviors could lead to HIV epidemic in Afghanistan - Cancer Vaccines
Drug in New Hepatitis C Clinical Trial - DNA Vaccines
Tripep has received approval to start a phase I/II study of the ChronVac-C vaccine as a treatment for chronic infections by the hepatitis C virus - Hepatitis C Virus
Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon Trial Ahead of Schedule - Hepatitis C Virus
Medical Services International Signs Agreement with US Biotech Firm to Begin Approval Process in the United States for the VScan TB and Hepatitis C Test Kits - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
